Steven D. Douglas, professor of pediatrics at the Perelman School of Medicine, University of Pennsylvania, and chief of the section of immunology at Children’s Hospital of Philadelphia, received the 2015 International Society for NeuroVirology (ISNV) Paradigm Builder Lectureship award in June.

Dr. Douglas is recognized for his seminal and continuous contributions to the field of leukocyte biology, with emphasis on monocyte/macrophage biology in HIV infection. His research has intersected the disciplines of psychiatry, immunology, neurology and AIDS, utilizing the antiemetic drug Aprepitant (an NK1R/SP antagonist) as a potential therapeutic agent for HIV infection.